WallStreetZenWallStreetZen

NASDAQ: OCUL
Ocular Therapeutix Inc Stock Forecast, Predictions & Price Target

Analyst price target for OCUL

Based on 4 analysts offering 12 month price targets for Ocular Therapeutix Inc.
Min Forecast
$12.00+11.63%
Avg Forecast
$15.00+39.53%
Max Forecast
$18.00+67.44%

Should I buy or sell OCUL stock?

Based on 4 analysts offering ratings for Ocular Therapeutix Inc.
Strong Buy
Strong Buy
2 analysts 50%
Buy
2 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their OCUL stock forecasts and price targets.

OCUL stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-02-26
lockedlocked$00.00+00.00%2024-02-14
lockedlocked$00.00+00.00%2024-02-09
lockedlocked$00.00+00.00%2023-09-14

1 of 1

Forecast return on equity

Is OCUL forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.11%

Forecast return on assets

Is OCUL forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

OCUL revenue forecast

What is OCUL's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$76.1M+31.8%
Avg 2 year Forecast
$103.9M+80.05%
Avg 3 year Forecast
$175.7M+204.34%
OCUL's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

OCUL revenue growth forecast

How is OCUL forecast to perform vs Biotechnology companies and vs the US market?
Company
42.76%
Industry
45.89%
Market
10.82%
OCUL's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
OCUL's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

OCUL vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
OCUL$10.75$15.00+39.53%Strong Buy
TYRA$19.93$23.00+15.40%Buy
EDIT$10.53$14.50+37.70%Strong Buy
TRML$42.59$49.75+16.81%Strong Buy
SLRN$8.63$14.80+71.49%Buy

Ocular Therapeutix Stock Forecast FAQ

Is Ocular Therapeutix Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: OCUL) stock is to Strong Buy OCUL stock.

Out of 4 analysts, 2 (50%) are recommending OCUL as a Strong Buy, 2 (50%) are recommending OCUL as a Buy, 0 (0%) are recommending OCUL as a Hold, 0 (0%) are recommending OCUL as a Sell, and 0 (0%) are recommending OCUL as a Strong Sell.

If you're new to stock investing, here's how to buy Ocular Therapeutix stock.

What is OCUL's revenue growth forecast for 2024-2026?

(NASDAQ: OCUL) Ocular Therapeutix's forecast annual revenue growth rate of 42.76% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 45.89%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.82%.

Ocular Therapeutix's revenue in 2024 is $57,716,000.On average, 3 Wall Street analysts forecast OCUL's revenue for 2024 to be $6,041,374,880, with the lowest OCUL revenue forecast at $5,514,035,203, and the highest OCUL revenue forecast at $7,078,582,135. On average, 2 Wall Street analysts forecast OCUL's revenue for 2025 to be $8,253,183,614, with the lowest OCUL revenue forecast at $6,253,422,611, and the highest OCUL revenue forecast at $10,252,944,617.

In 2026, OCUL is forecast to generate $13,950,278,750 in revenue, with the lowest revenue forecast at $7,061,110,038 and the highest revenue forecast at $20,839,447,462.

What is OCUL's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: OCUL) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is OCUL's Price Target?

According to 4 Wall Street analysts that have issued a 1 year OCUL price target, the average OCUL price target is $15.00, with the highest OCUL stock price forecast at $18.00 and the lowest OCUL stock price forecast at $12.00.

On average, Wall Street analysts predict that Ocular Therapeutix's share price could reach $15.00 by Feb 26, 2025. The average Ocular Therapeutix stock price prediction forecasts a potential upside of 39.53% from the current OCUL share price of $10.75.

What is OCUL's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: OCUL) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.